Rationality of routine clinical use of olokizumab in COVID-19

Routine clinical use of olokizumab in COVID-19 is not recommended. The use of olokizumab is possible in clinical trials.

Saved in:

Bibliographic Details
Main Authors:	V. M. Tsvetov (Author), A. V. Matveev (Author), D. A. Sychev (Author)
Format:	Book
Published:	Izdatelstvo OKI, 2020-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

Holdings details from 3rd Floor Main Library
Call Number:	A1234.567
Copy 1	Available